Omics technologies and the choice of treatment strategy for inflammatory intestinal diseases
The technologies of «omics» sciences (epigenetics, genetics, nutrigenetics, etc.) are gradually entering clinical practice and influencing the choice of treatment strategy. This is fully applied to genetically determined inflammatory intestinal diseases. These diseases are characterized by more severe course, frequent surgical complications and nutritional disorders as a rule. Early surgical treatment with clearly defined nutritional correction are advisable for genetically determined inflammatory intestinal diseases followed by refractory disorders. Early repair allows to avoid toxic dilatation, perforation, malignancy, severe metabolic syndromes.